Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Luther

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusM Zumbach, M Hofmann, V Borcea, et al.
Journal of Immunological Methods|March 22, 2000
A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functionsW Helfrich, H J Haisma, V Magdolen, et al.
International Journal of Oncology|September 21, 2000
New ELISA for quantitation of human urokinase receptor (CD87) in cancerM Kotzsch, T Luther, N Harbeck, et al.
Diabetes|September 1, 1997
Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cellsA Bierhaus, S Chevion, M Chevion, et al.
Annals of the New York Academy of Sciences|April 15, 1997
Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen systemP Carmeliet, L Moons, M Dewerchin, et al.
Anticancer Research|March 2, 2005
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancerB Werle, M Kotzsch, T T Lah, et al.
Nature|September 5, 1996
Role of tissue factor in embryonic blood vessel developmentP Carmeliet, N Mackman, L Moons, et al.
Gastroenterology|July 1, 1997
Evidence for an ATP-dependent bile acid transport protein other than the canalicular liver ecto-ATPase in ratsT T Luther, P Hammerman, C M Rahmaoui, et al.
The American Journal of Pathology|July 6, 2000
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathyD N Müller, E M Mervaala, R Dechend, et al.
Nature|December 31, 1997
Mice lacking factor VII develop normally but suffer fatal perinatal bleedingE D Rosen, J C Chan, E Idusogie, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusM Zumbach, M Hofmann, V Borcea, et al.
Journal of Immunological Methods|March 22, 2000
A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functionsW Helfrich, H J Haisma, V Magdolen, et al.
International Journal of Oncology|September 21, 2000
New ELISA for quantitation of human urokinase receptor (CD87) in cancerM Kotzsch, T Luther, N Harbeck, et al.
Diabetes|September 1, 1997
Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cellsA Bierhaus, S Chevion, M Chevion, et al.
Annals of the New York Academy of Sciences|April 15, 1997
Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen systemP Carmeliet, L Moons, M Dewerchin, et al.
Anticancer Research|March 2, 2005
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancerB Werle, M Kotzsch, T T Lah, et al.
Nature|September 5, 1996
Role of tissue factor in embryonic blood vessel developmentP Carmeliet, N Mackman, L Moons, et al.
Gastroenterology|July 1, 1997
Evidence for an ATP-dependent bile acid transport protein other than the canalicular liver ecto-ATPase in ratsT T Luther, P Hammerman, C M Rahmaoui, et al.
The American Journal of Pathology|July 6, 2000
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathyD N Müller, E M Mervaala, R Dechend, et al.
Nature|December 31, 1997
Mice lacking factor VII develop normally but suffer fatal perinatal bleedingE D Rosen, J C Chan, E Idusogie, et al.
Pageof 8